載入...
Atypical Antipsychotic Exposure May Not Differentiate Metabolic Phenotypes of Patients with Schizophrenia
STUDY OBJECTIVE: Patients with schizophrenia are known to have higher rates of metabolic disease than the general population. Contributing factors likely include lifestyle and atypical antipsychotic (AAP) use, but the underlying mechanisms are unknown. The objective of this study was to identify met...
Na minha lista:
發表在: | Pharmacotherapy |
---|---|
Main Authors: | , , , , , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
2018
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6014920/ https://ncbi.nlm.nih.gov/pubmed/29722909 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/phar.2119 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|